Intellia Therapeutics Inc NTLA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/18/21 EDT
75.93quote price arrow up+0.01 (+0.01%)
Volume
38,174
Close
75.92quote price arrow down-0.58 (-0.76%)
Volume
1,946,878
52 week range
16.54 - 92.00

...

Loading . . .
  • Open74.87
  • Day High77.15
  • Day Low74.65
  • Prev Close76.50
  • 52 Week High92.00
  • 52 Week High Date01/15/21
  • 52 Week Low16.54
  • 52 Week Low Date09/04/20

Key Stats

  • Market Cap5.174B
  • Shares Out68.15M
  • 10 Day Average Volume1.37M
  • Dividend-
  • Dividend Yield-
  • Beta2.01
  • YTD % Change39.56

KEY STATS

  • Open74.87
  • Day High77.15
  • Day Low74.65
  • Prev Close76.50
  • 52 Week High92.00
  • 52 Week High Date01/15/21
  • 52 Week Low16.54
  • 52 Week Low Date09/04/20
  • Market Cap5.174B
  • Shares Out68.15M
  • 10 Day Average Volume1.37M
  • Dividend-
  • Dividend Yield-
  • Beta2.01
  • YTD % Change39.56

RATIOS/PROFITABILITY

  • EPS (TTM)-2.46
  • P/E (TTM)-30.90
  • Fwd P/E (NTM)-28.33
  • EBITDA (MRQ)-143.599M
  • ROE (MRQ)-37.46%
  • Revenue (MRQ)51.52M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-288.47%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Intellia Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Intellia Therapeutics, Inc. is a genome editing company. The Company is focused on developing therapeutics utilizing a biological tool known as CRISPR/Cas9. The CRISPR/Cas9 genome editing system includes two components: the Cas9 protein and the guide RNA sequence. The Cas9 protein acts like a pair of molecular scissors that initiates the natural cellular repair process to knockout, repair or insert a gene. The guide RNA sequence recognizes and directs the Cas9 to a specific...
Frank Verwiel M.D.
Non-Executive Chairman
John Leonard M.D.
President
Andrew Schiermeier Ph.D.
Chief Operating Officer
Glenn Goddard
Chief Financial Officer
Jose Rivera J.D.
Executive Vice President
Address
40 Erie St Ste 130
Cambridge, MA
02139-4254
United States

Top Peers

SYMBOLLASTCHG%CHG
VIR
Vir Biotechnology Inc
46.15+2.33+5.32%
PACB
Pacific Biosciences of California Inc
29.15-0.40-1.35%
IBRX
Immunitybio Inc
13.41-0.49-3.53%
TWST
Twist Bioscience Corp
111.25-2.20-1.94%
BEAM
Beam Therapeutics Inc
85.00UNCHUNCH